Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Editorial Policies

Editorial Policies

Focus and Scope

JMIR Cardio focuses on cardiovascular medicine with a special emphasis on health services research and electronic / digital health approaches in cardiology and for cardiovascular health, which includes ehealth and mhealth approaches for the prevention and treatment of cardiovascular conditions. JMIR Cardio is an open access journal.

JMIR Cardio is indexed in PubMed, PubMed Central (PMC), Sherpa Romeo, DOAJ, MEDLINE, and Scopus. With a CiteScore of 3.5, JMIR Cardio is a Q2 journal in the field of Cardiology and Cardiovascular Medicine, according to Scopus data.

Section Policies

General Articles in Cardiology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Novel Sensors and Data Acquisition Methods in Cardiology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Mobile Apps for Cardiology

Editors
  • Ponrathi Athilingam, University of South Florida
Checked Open Submissions Checked Indexed Checked Peer Reviewed

Heart Failure Self-Management

Checked Open Submissions Checked Indexed Checked Peer Reviewed

e-Cardiology and Telemonitoring in Cardiology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Innovations in Cardiopulmonary Resuscitation

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cardiac Rehabilitation

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Viewpoints and Proposals

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Reviews on Cardiovascular Health and Medicine

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cardiac Disease Management

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cardiac Self-Management

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Hypertension Prevention and Treatment

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Patient-Views on Cardiology Technology and Innovations

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Stroke

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Coronary Heart Disease

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Myocardial Infarction (Heart Attack)

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cardiac Risk and Cardiac Risk Calculators

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Patient Education in Cardiology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Implantable Cardioverter Defibrillator (ICD) Care and Innovations

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cardiovascular Disease Prevention

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cardiac Surgery

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Corrigenda and Addenda

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Discretionary Corrigenda

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Cardiac Arrhythmia, Atrial Fibrillation

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Sleep Apnea

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Letters to the Editor

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Congenital Heart Disease

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Patient Satisfaction and Quality of Care in Cardiology and Digital Cardiology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Editorial

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Theme Issue (2023): Generative & Multimodal AI in Digital Cardiovascular Medicine

Special Issue focusing on applications of generative and multimodal artificial intelligence in cardiology

Call for papers 

Guest Editors

Gunther Eysenbach, MD, MPH, FACMI

Founding Editor and Publisher, JMIR

gunther.eysenbach@jmir.org

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Research Letter

Research Letters present new, early, or preliminary research findings. The text should use standard research headings of Introduction, Methods, Results, and Discussion and should be no longer than 750 words, with a maximum of 10 references and 2 tables or figures. The APF for Research Letters accepted after peer review is lower than the standard APF.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Heart Valve Disease Research

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cardiac Diagnostics

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cardiovascular Medical Education and Training for Health Professionals

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

When we receive a manuscript, an assessment will be made to ensure the manuscript meets the formal criteria specified in the Instructions for Authors and that it fits within the scope of the journal. When in doubt, the editor will consult other members of the Editorial Board. Manuscripts are then assigned to an Associate Editor or Section Editor (Associate Editor who is responsible for a topic-based section of the journal) to send to 2-4 external experts for peer review. The Associate Editor or Section Editor makes editorial decisions on the peer-reviewed manuscript; the final decision on acceptance rests with the Editor-in-Chief. Authors are required to suggest at least 2 peer-reviewers (who do not have a conflict of interest) during the submission process. 

Peer reviewing is a single-blind process as the reviewers are aware of the names of the authors. Review feedback is anonymous when shared with the authors during the review process. Reviewers for JMIR journals will not stay anonymous as their names appear at the end of the published article. Authors and reviewers should not contact each other directly to discuss manuscripts or reviews.

Speed of Peer-Review

The Internet is a fast-moving field and we acknowledge the need of our authors to communicate their findings rapidly. We therefore aim to be extremely fast (but still thorough and rigorous) in our peer-review process. For example, the paper "Factors Associated with Intended Use of a Web Site Among Family Practice Patients" (J Med Internet Res 2001;3(2):e17) was reviewed, edited, type-set and published within only 16 days. Including the two weeks time authors needed to revise their article, from first submission to final publication less than 1 month passed (note that current turnaround times needed to review and edit papers vary, and primarily depend on the quality of the paper upon first submission!). Normally we can not give any guarantees on the speed of peer-review or publication - except if a paper has been submitted under the fast-track scheme, where we guarantee an editorial decision within 20 working days (4 weeks) and publication of the article within 4 weeks after acceptance. We aim for an average decision time of 2 months after submission for papers sent out for peer-review. There will however always be outliers (papers which are more difficult to evaluate).

Current statistics on turnaround time show that on average it takes 50 days to make an initial decision (29 days for fast-tracked papers) (see 1.4 on the stats page).

Criteria for Selection of Manuscripts

Manuscripts should meet the following criteria: the study conducted is ethical (see below); the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data; the information is important; and the topic is interesting for our readership. It is recognized that many submissions will describe websites and other Internet-based services. The Editorial Board strongly recommends that authors of such submissions make efforts to evaluate and if possible quantify the impact of these services. Submissions containing evaluations are more likely to be accepted than those containing descriptions of services alone, unless the service includes significant innovation. More descriptive papers - ideally with an evaluation plan - can be submitted to JMIR Res Protoc. Formative research, feasibility and pilot studies should be submitted to JMIR Formative Res (see also Publication Strategy article in our Knowledge Base).

Ethical Issues

Internet-based research raises novel questions of ethics and human dignity (see for example KB article on Ethics in Social Media Research). If human subjects are involved, informed consent, protection of privacy and other human rights are further criteria against which the manuscript will be judged. Papers describing investigations on human subjects must include a statement that the study was approved by the institutional review board, in accordance with all applicable regulations, and that informed consent was obtained after the nature and possible consequences of the studies were explained. JMIR is also encouraging articles devoted to the ethics of Internet-based research. In addition, as mentioned in the conflict of interest article, we will ask authors to disclose any competing interests in relation to their work.

For more information on JMIR Publications' ethics policies, please visit our Knowledge Base (KB), here.

Publication Frequency

This journal publishes articles continuously, i.e. articles are published online as soon as they are available (peer-reviewed and copy-edited).

Open Access Policy

All journals published by JMIR Publications provide immediate open access to their content on the principle that making research freely available to the public supports a greater global exchange of knowledge and accelerates research. Copyright is retained by the authors, and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by JMIR Publications, is properly cited. The complete bibliographic information (authors, title, journal, volume/issue, and article ID), a link to the original publication (URL), and this copyright and license information (“Licensed under Creative Commons Attribution cc-by 4.0”) must be included.

Please do not contact the publisher for “reprint permission” requests because, by default, this permission has already been given by authors (under the condition of attribution of the original source), and the publisher does NOT own the copyright for the material published. The authors retain the copyright, unless stated otherwise.

Editor-in-Chief

Andrew J. Coristine, PhD, Affiliate Faculty, Department of Medicine (Division of Cardiology), McGill University (Canada); Scientific Editor, JMIR Publications (Canada)

Editorial Board

Editor-in-Chief

Andrew J. Coristine, PhD

Affiliate Faculty, Department of Medicine (Division of Cardiology), McGill University (Canada); Scientific Editor, JMIR Publications (Canada)

Dr. Andrew J. Coristine is an affiliate faculty member in the Department of Medicine, Division of Cardiology, at McGill University. His research focuses on cardiac imaging, cardiovascular epidemiology, and the intersection of these fields with digital health. Additionally, he has published work on rapid magnetic resonance imaging and deep learning approaches to cardiac image reconstruction.

Submissions are accepted via our web-based submission system

JMIR Cardio is seeking an Editor-in-Chief and Associate Editors! Read about the roles at How can I apply to become an editorial board member? and apply for an Editorial Board position with the journal.

Denise Kuo, BA, Managing Editor

Editorial Board Members

Associate Editors

Nitesh Ainani, MD, FACC, FSCAI, RPVI

Interventional Cardiologist, Tidelands Health with Medical University of South Carolina (MUSC) Health, USA

Dr. Ainani is a board certified Interventional Cardiologist currently practicing medicine in the United States. His research interests include the fields of Internal medicine, Cardiovascular Diseases, and Interventional Cardiology. His clinical experience and research focuses on the areas of valvular heart disease, coronary artery diseases, congestive heart failure, and cardiomyopathies.

Goran Krstačić MD, PhD, FESC, FEHRA

Director, Institute for Cardiovascular Prevention and Rehabilitation, Zagreb, Croatia

Goran Krstačić is a specialist in internal medicine and cardiology and a graduate of Health Manager School He is the director of the Institute for Cardiovascular Prevention and Rehabilitation in Zagreb, Croatia, and a professor of cardiology at the School of Medicine in Osijek and the Faculty of Dental Medicine and Health at the University of Osijek. Dr. Krstačić is also the chair of the European Society of Cardiology Working Group on e-Cardiology, a coordinator of the topic on e-Technology and a board member of the European Heart Rhythm Association and the Computing in Cardiology Association. His research interests include digital health in cardiology and cardiac rehabilitation.  

John T. Rivers, FRACP, SIA, FCSANZ, GAICD, MB, BSc (Med), BS (Hons) 

Cardiologist, St. Andrew’s War Memorial Hospital, Mater Private Hospital, Brisbane, Australia

John Rivers is a cardiologist with extensive research achievements including the publication of over 50 scientific articles in journals such as the New England Journal of Medicine, Circulation, and the Journal of the American College of Cardiology. The research focus over his clinical career has been on improving patient outcomes by building systems for measuring and improving clinical practices and integrating this with routine clinical care and governance. He is currently working on digital transformation of cardiac care models.

Aniruddha Singh, MD, FACC, FNLA

Director, Cardiovascular Fellowship, Tower Health/Drexel University College of Medicine, USA

Dr. Singh is the Program Director for the General Cardiovascular Fellowship program at Drexel University College of Medicine at Tower Health in West Reading, Pennsylvania. He is board certified in Cardiology, Internal Medicine, Echocardiography, Cardiac Computed Tomography, Nuclear Cardiology and Vascular Ultrasonography and has earned a Master in Lipidology through the National Lipid Association. Dr. Singh serves on various state and national committees with the American College of Cardiology and the National Lipid Association, and also volunteers as a Content Expert for the Alliance for Physician Certification & Advancement. Previously, Dr. Singh was Assistant Professor of Medicine and Research Chairman for the GME programs at the University of Kentucky College of Medicine in Bowling Green, Kentucky. He was the Internal Medicine Clerkship Director for third- and fourth-year medical students and later transitioned to the role of Associate Program Director of the Cardiovascular Fellowship.

Kam Cheong Wong, PhD, MBBS, MSc, BEng

Senior Research Fellow, University of Sydney; Senior Lecturer, Western Sydney University

Dr Kam Wong is a published medical researcher who combines 20 years of clinical experience with 10 years of engineering work to advance digital health solutions for cardiovascular care. With a PhD from the University of Sydney, Dr Wong focuses on leveraging digital health technology to enhance the early detection and management of cardiovascular conditions. His research has proven the feasibility and effectiveness of remote health innovations in screening for atrial fibrillation, underscoring his commitment to making heart health services accessible in real-world settings. 

Advisors

Avik Ray, MD, MS

Postdoctoral Research Fellow, Brigham and Women's Hospital, Harvard Medical School, USA

Dr. Ray is a medical doctor with a specialization in medicine and pharmacoepidemiology. His professional journey has been an exciting mixture of patient care, population health, data science, and management. Dr. Ray had his first entrepreneurial stint in the provider space in medical school which gave him invaluable first-hand experiences of building products from the scratch. He did his residency in clinical pharmacology during which Dr. Ray carried out clinical trials and served as an academic consultant to life sciences organizations. He has published multiple scientific papers in reputed international journals including the New England Journal of Medicine and the Lancet. Dr. Ray graduated with a Master of Science degree in Epidemiology from Harvard University which allowed him to imbibe advanced data science skills to complement his holistic understanding of healthcare and the pharmaceutical industry. His area of focus is cardiovascular medicine and real-world data analysis using causal inference and state-of-the-art machine learning techniques. Dr. Ray is currently a postdoctoral fellow at Brigham and Women's Hospital/Harvard Medical School and his research involves analysis of real-world evidence of medicines and vaccines to assess effectiveness and safety, thus providing critical inputs for treatment guideline updates and health policy decisions. He has received multiple prestigious scholarships, fellowships, awards, and other accolades including an invite to attend the Nobel Laureate Meeting on Medicine/Physiology by the Nobel Prize Council as a MARS fellow and has been inducted as a fellow of the Royal Society for Public Health (FRSPH). 

Past Editorial Board Members

Ponrathi Athilingam, PhD, ACNP, MCH, FAAN, Associate Professor, University of South Florida, College of Nursing, USA

Nico Bruining, PhD, Former Editor-in-Chief Thoraxcenter, Department of Cardiology, Erasmus MC, Rotterdam, Netherlands

Ruben Casado Arroyo, MD, PhD, MSc, FESC, Professor of Medicine, Director of the Cardiac Electrophysiology Laboratory, CUB Hopital Erasme, Université Libre de Bruxelles, Belgium

Paul Cummins, PhD, Department of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands

Vasundhara Muthu, MD, FACC, Cardiologist, University of Maryland, Upstate Medical University, Glen Burnie, Maryland, USA 

Aaron Peace, MD, PhD, MRCPI, FRCPEd, FESC, Chief Executive Officer, Clinical Translational Research and Innovation Centre (C-TRIC), Western Health and Social Care Trust, Londonderry, UK

Past Staff Scientific Editors

Tiffany I. Leung, MD, MPH, FACP, FAMIA, FEFIM

Amaryllis Mavragani, MSc, BSc

Join the Editorial Board

How can I apply to become an editorial board member?

We are currently looking to expand our Editorial Board. To apply to be an Editorial Board Member/Associate Editor, please apply using the form linked in this article. You should hold a PhD (or similar higher degree), have a publication track record (h-index>8), and ideally have some academic editing experience. 

Guest Editors

We are also seeking guest editors who may wish to compile a theme issue on a special subtopic. Click here for more information on how to suggest a theme issue.

This may be particularly interesting for workshop and conference organizers putting together a grant-funded event (eg, with invited experts) on an eHealth-related topic. JMIR can then be used as a dissemination vehicle.

The task of the Guest Editor(s) is generally to:

  • Solicit manuscripts from colleagues concerning the selected topic;
  • Select peer-reviewers for incoming manuscripts;
  • Make decisions (together with the editorial board) on article revisions and acceptance;
  • Write an editorial for the theme issue; and/or
  • Secure funding to sponsor the APFs for published papers (usually in the $10-20k range).

Alternately, the abstracts of the conference may be published in a supplement in iProc, with selected full papers published later in a theme issue or in regular JMIR issues.

Indexing and Impact Factor

JMIR Cardio (2561-1011) is indexed in PubMed, PubMed Central (PMC), Sherpa Romeo, DOAJ, MEDLINE, and Scopus.

JMIR Cardio received a CiteScore of 3.5, placing it in the 54th percentile (#175 of 387) as Q2 journal in the field of Cardiology and Cardiovascular Medicine, according to Scopus data.

JMIR Cardio has met the editorial criteria for inclusion  in the Web of Science™. JMIR Cardio may receive its inaugural journal impact factor as early as 2025.